SCHEMBL10132906

SCHEMBL10132906

O=C(NCc1ccccc1)Nc1ccc(-c2ccc(OCN3CCOCC3)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.57
MAPT P10636 2/20 0.56
ALDH1A1 P00352 2/20 0.56
AURKA O14965 2/20 0.54
AURKB Q96GD4 1/20 0.54
KDR P35968 3/20 0.54
FLT3 P36888 3/20 0.54
ABL1 P00519 1/20 0.53
TUBB4A P04350 1/20 0.53
TUBB P07437 1/20 0.53
LYN P07948 1/20 0.53
TUBA3C P0DPH7 1/20 0.53
BCR P11274 1/20 0.53
SRC P12931 1/20 0.53
TUBA1B P68363 1/20 0.53
TUBA4A P68366 1/20 0.53
TUBB4B P68371 1/20 0.53
TUBB3 Q13509 1/20 0.53
TUBB2A Q13885 1/20 0.53
TUBB8 Q3ZCM7 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10132797 0.90 EPHX2 (0.67) EPHX2MAPTALDH1A1AURKAAURKB
SCHEMBL10132925 0.89 EPHX2 (0.75) EPHX2MAPTAURKAAURKBKDR
SCHEMBL10132893 0.85 ABL1 (0.55) EPHX2MAPTALDH1A1AURKAKDR
SCHEMBL10132913 0.84 SRC (0.64) EPHX2MAPTALDH1A1ABL1TUBB4A
SCHEMBL10132914 0.84 SRC (0.64) EPHX2MAPTALDH1A1ABL1TUBB4A
SCHEMBL10132799 0.78 TUBB4A (0.73) EPHX2AURKAAURKBKDRFLT3
SCHEMBL10132802 0.78 EPHX2 (0.58) EPHX2AURKAAURKBKDRFLT3
SCHEMBL10132968 0.78 AURKA (0.61) EPHX2ALDH1A1AURKAAURKBKDR
SCHEMBL10132884 0.78 BCHE (0.55) MAPTABL1TUBB4ATUBBLYN
SCHEMBL10132903 0.77 SMN1; SMN2 (0.50) EPHX2MAPTALDH1A1ABL1TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124605-B2 Compositions and methods for modulating a kinase cascade KINEX PHARMACEUTICALS, LLC (US) 2012-02-28 US disclosed
US-8124605-B2 Compositions and methods for modulating a kinase cascade KINEX PHARMACEUTICALS, LLC (US) 2012-02-28 US disclosed
US-20090149510-A1 Compositions and methods for modulating a kinase cascade OAKTREE FUND ADMINISTRATION, LLC 2009-06-11 US disclosed
US-20090149510-A1 Compositions and methods for modulating a kinase cascade OAKTREE FUND ADMINISTRATION, LLC 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149510-A1 Compositions and methods for modulating a kinase cascade MAP3K6, MAP3K4, MAP3K3 EPHX2 2377/4885MAPT 2664/4885ALDH1A1 4811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.